Hepatitis Monthly

Published by: Kowsar

Immune Responses to Single-Dose Versus Double-Dose Hepatitis B Vaccines in Healthcare Workers not Responding to the Primary Vaccine Series: A Randomized Clinical Trial

Farahnaz Joukar 1 , Fariborz Mansour-Ghanaei 1 , * , Mohammad-Reza Naghipour 1 and Mehrnaz Asgharnezhad 1
Authors Information
1 Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, Rasht, IR Iran
Article information
  • Hepatitis Monthly: February 01, 2016, 16 (2); e32799
  • Published Online: February 27, 2016
  • Article Type: Research Article
  • Received: August 30, 2015
  • Revised: January 25, 2016
  • Accepted: January 27, 2016
  • DOI: 10.5812/hepatmon.32799

To Cite: Joukar F, Mansour-Ghanaei F, Naghipour M, Asgharnezhad M. Immune Responses to Single-Dose Versus Double-Dose Hepatitis B Vaccines in Healthcare Workers not Responding to the Primary Vaccine Series: A Randomized Clinical Trial, Hepat Mon. 2016 ; 16(2):e32799. doi: 10.5812/hepatmon.32799.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, et al. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015; 13(1): 183-92[DOI][PubMed]
  • 2. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2005; 34 Suppl 1-3[PubMed]
  • 3. MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015; 5(5)[DOI][PubMed]
  • 4. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003): 1546-55[DOI][PubMed]
  • 5.
  • 6. Hepatitis B. Fact sheet.
  • 7. Beekmann SE, Henderson DK. Occupational Exposures among Healthcare Workers: New Methods for Prevention and Recommended Postexposure Prophylaxis for HIV and Hepatitis B and C. Curr Treat Options Infect Dis. 2015; 7(1): 28-38[DOI]
  • 8. Mueller A, Stoetter L, Kalluvya S, Stich A, Majinge C, Weissbrich B, et al. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania. BMC Infect Dis. 2015; 15: 386[DOI][PubMed]
  • 9. Abeje G, Azage M. Hepatitis B vaccine knowledge and vaccination status among health care workers of Bahir Dar City Administration, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2015; 15: 30[DOI][PubMed]
  • 10. Panlilio AL, Orelien JG, Srivastava PU, Jagger J, Cohn RD, Cardo DM. Estimate of the annual number of percutaneous injuries among hospital-based healthcare workers in the United States, 1997-1998. Infect Control Hosp Epidemiol. 2004; 25(7): 556-62[DOI][PubMed]
  • 11. Lewis JD, Enfield KB, Sifri CD. Hepatitis B in healthcare workers: Transmission events and guidance for management. World J Hepatol. 2015; 7(3): 488-97[DOI][PubMed]
  • 12. Shefer AM, Healthcare Infection Control Practices Advisory Committee . Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). 2011;
  • 13. Halperin SA, McNeil S, Langley JM, Smith B, MacKinnon-Cameron D, McCall-Sani R, et al. Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults. Vaccine. 2012; 30(36): 5445-8[DOI][PubMed]
  • 14. Romano L, Paladini S, Van Damme P, Zanetti AR. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis. 2011; 43 Suppl 1-7[DOI][PubMed]
  • 15. Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, et al. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine. 2004; 22(5-6): 607-10[PubMed]
  • 16. Wiersma ST. Hepatitis B vaccine continues to provide long-term protection to healthcare workers. J Hepatol. 2009; 51(4): 826[DOI][PubMed]
  • 17. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005; 54: 1-31[PubMed]
  • 18. Chathuranga LS, Noordeen F, Abeykoon AM. Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka. Int J Infect Dis. 2013; 17(11)-9[DOI][PubMed]
  • 19. Perera J, Perera B, Gamage S. Seroconversion after hepatitis B vaccination in healthy young adults, and the effect of a booster dose. Ceylon Med J. 2002; 47(1): 6-8[PubMed]
  • 20. Praharaj I, John SM, Bandyopadhyay R, Kang G. Probiotics, antibiotics and the immune responses to vaccines. Philos Trans R Soc Lond B Biol Sci. 2015; 370(1671)[DOI][PubMed]
  • 21. Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol. 2006; 78(2): 169-77[DOI][PubMed]
  • 22. Jha R, Lakhtakia S, Jaleel MA, Narayan G, Hemlatha K. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders. Ren Fail. 2001; 23(5): 629-36[PubMed]
  • 23. Chou HY, Lin XZ, Pan WY, Wu PY, Chang CM, Lin TY, et al. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells. J Immunol. 2010; 185(9): 5468-75[DOI][PubMed]
  • 24. Hasan MS, Agosti JM, Reynolds KK, Tanzman E, Treanor JJ, Evans TG. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults. J Infect Dis. 1999; 180(6): 2023-6[DOI][PubMed]
  • 25. Schirmer A, Alter K, Kotz SA, Friederici AD. Lateralization of prosody during language production: a lesion study. Brain Lang. 2001; 76(1): 1-17[DOI][PubMed]
  • 26. Rendi-Wagner P, Shouval D, Genton B, Lurie Y, Rumke H, Boland G, et al. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine. 2006; 24(15): 2781-9[DOI][PubMed]
  • 27. Zuckerman JN, Sabin C, Craig FM, Williams A, Zuckerman AJ. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study. BMJ. 1997; 314(7077): 329-33[PubMed]
  • 28. Bookstaver PB, Foster JL, Lu ZK, Mann JR, Ambrose C, Grant A, et al. Hepatitis B virus seroconversion rates among health sciences students in the southeastern United States. J Am College Health. 2016; 64(1): 69-73
  • 29. Cardell K, Akerlind B, Sallberg M, Fryden A. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis. 2008; 198(3): 299-304[DOI][PubMed]
  • 30. David MC, Ha SH, Paynter S, Lau C. A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination. Vaccine. 2015; 33(48): 6564-9[DOI][PubMed]
  • 31. Bahmani MK, Khosravi A, Mobasser A, Ghezelsofla E. Seroprevalence of hepatitis B virus infection and vaccination compliance among health care workers in Fars Province, Iran. Arch Clin Infect Dis. 2010; 5(1): 45-50
  • 32. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002; 35(11): 1368-75[DOI][PubMed]
  • 33. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA. 1993; 270(24): 2935-9[PubMed]
  • 34. Bender TJ, Sharapov U, Utah O, Xing J, Hu D, Rybczynska J, et al. Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility--Virginia, 2010. Vaccine. 2014; 32(7): 852-6[DOI][PubMed]
  • 35. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med. 2004; 351(27): 2832-8[DOI][PubMed]
  • 36. Poland GA. Hepatitis B immunization in health care workers. Dealing with vaccine nonresponse. Am J Prev Med. 1998; 15(1): 73-7[PubMed]
  • 37. Sjogren MH. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med. 2005; 118 Suppl 10A: 34S-9S[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments